InvestorsHub Logo
Followers 70
Posts 11387
Boards Moderated 0
Alias Born 01/05/2018

Re: snayeman post# 388498

Wednesday, 03/02/2022 1:27:17 PM

Wednesday, March 02, 2022 1:27:17 PM

Post# of 403074
You are correct. First mistake was letting Dr B go with P ahead of Brilacidin for OM development. The B-OM Phase 3 if passed would have at least started a steady revenue stream and possibly led to a merger or major investment of sorts by a Big Pharma. Now we are left hoping we find the “hidden carrot” amongst the secondary and CU results. Beyond frustrating. And I have voiced this opinion personally to Leo!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News